Stock Performance and Market Context
On 10 Feb 2026, Acutaas Chemicals Ltd’s stock surged to an intraday high of Rs.2120, representing a 5.95% increase from the previous close. The stock outperformed its sector by 3.92% and has recorded gains for three consecutive days, delivering a cumulative return of 4.87% during this period. This rally has propelled the stock well above its key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, signalling strong technical momentum.
In comparison, the Sensex opened 144.25 points higher and was trading at 84,389.64, up 0.39%, on the same day. The benchmark index is currently 2.1% shy of its own 52-week high of 86,159.02 and has been on a three-week consecutive rise, gaining 3.5%. Mega-cap stocks have been leading the market’s advance, contributing to the positive sentiment.
Long-Term Growth and Financial Strength
Acutaas Chemicals Ltd has demonstrated impressive long-term growth fundamentals. Over the past year, the stock has delivered a remarkable 67.11% return, significantly outpacing the Sensex’s 9.16% gain. The company’s 52-week low stood at Rs.930.03, highlighting the substantial appreciation in share price over the period.
The company’s financial metrics underpin this strong performance. Net sales have grown at an annual rate of 26.84%, while operating profit has expanded by 38.56%. Net profit growth has been even more pronounced, rising by 47.82%, with the company declaring outstanding results in December 2025. This marks six consecutive quarters of positive results, underscoring consistent operational strength.
Balance Sheet and Efficiency Metrics
Acutaas Chemicals Ltd maintains a conservative capital structure with an average debt-to-equity ratio of zero, indicating no reliance on debt financing. This low leverage supports financial stability and reduces risk exposure.
Efficiency ratios further highlight the company’s operational excellence. The Return on Capital Employed (ROCE) for the half-year period reached a high of 21.30%, while inventory turnover ratio stood at 5.74 times and debtors turnover ratio at 3.76 times. These figures reflect effective asset utilisation and strong working capital management.
Turnaround taking shape! This Small Cap from NBFC sector just hit profitability with strong business fundamentals showing up. Catch it before the major breakout happens!
- - Recently turned profitable
- - Strong business fundamentals
- - Pre-breakout opportunity
Valuation and Market Standing
The company’s valuation metrics indicate a premium positioning. With a Return on Equity (ROE) of 15.8% and a Price to Book Value of 11.6, Acutaas Chemicals Ltd is considered very expensive relative to its peers. However, the Price/Earnings to Growth (PEG) ratio of 0.4 suggests that the stock’s price growth is supported by strong earnings expansion, as profits have risen by 136% over the past year.
Institutional investors hold a significant 38.38% stake in the company, reflecting confidence from entities with extensive analytical resources. Acutaas Chemicals Ltd is ranked among the top 1% of companies rated by MarketsMojo across a universe of 4,000 stocks, securing the 5th position among Small Cap companies and 18th across the entire market.
Market-Beating Returns and Technical Strength
In addition to its one-year return of 67.11%, Acutaas Chemicals Ltd has outperformed the BSE500 index over the last three years, one year, and three months. The stock’s consistent upward trajectory is supported by its trading above all major moving averages, signalling sustained bullish momentum.
Today’s 3.85% day change further emphasises the stock’s outperformance relative to the sector and broader market indices. This momentum is a testament to the company’s strong fundamentals and market positioning within the Pharmaceuticals & Biotechnology sector.
Want to dive deeper on Acutaas Chemicals Ltd? There's a real-time research report diving right into the fundamentals, valuations, peer comparison, financials, technicals and much more!
- - Real-time research report
- - Complete fundamental analysis
- - Peer comparison included
Summary of Key Metrics
To summarise, Acutaas Chemicals Ltd’s recent surge to Rs.2120 marks a new 52-week high, supported by:
- Strong 1-year return of 67.11% versus Sensex’s 9.16%
- Consistent quarterly positive results over six quarters
- Robust net sales growth at 26.84% annually
- Operating profit growth of 38.56% and net profit growth of 47.82%
- High ROCE of 21.30% and efficient inventory and debtor turnover ratios
- Zero debt-to-equity ratio, indicating a debt-free balance sheet
- Significant institutional holdings at 38.38%
- Strong technical positioning above all major moving averages
These factors collectively underpin the stock’s strong performance and its status as a leading player in the Pharmaceuticals & Biotechnology sector.
Market Environment and Sector Performance
The broader market environment has been favourable, with the Sensex trading above its 50-day and 200-day moving averages, indicating a bullish trend. The index’s proximity to its own 52-week high and the leadership of mega-cap stocks have contributed to positive sentiment across sectors, including Pharmaceuticals & Biotechnology.
Acutaas Chemicals Ltd’s outperformance relative to its sector and the broader market highlights its resilience and ability to capitalise on favourable market conditions.
Conclusion
Acutaas Chemicals Ltd’s achievement of a new 52-week high at Rs.2120 is a clear reflection of its strong financial health, operational efficiency, and sustained market momentum. The stock’s consistent gains over recent days, coupled with its impressive long-term returns and robust fundamentals, position it as a noteworthy performer within its sector.
Upgrade at special rates, valid only for the next few days. Claim Your Special Rate →
